Kraig Biocraft Laboratories to Host a Shareholder Conference Call Later Today
June 10 2011 - 6:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced that
its CEO, Kim Thompson, will participate in a shareholder conference
call later today, Friday, June 10, 2011 at 4:30 p.m. EDT. The
conference call will be open to all shareholders and other
interested parties.
Kim Thompson, the Company's CEO and founder, will review the
recent Sigma-Aldrich agreement and upcoming laboratory
developments, as well as what is in the recombinant spider silk
commercialization pipeline.
Interested parties are invited to dial the toll-free number
below.
1-866-906-9888 and when prompted enter access code 4073683
followed by the # (pound) sign.
It is recommended that callers dial in approximately five
minutes before the conference is scheduled to begin.
About Kraig Biocraft Laboratories
Kraig Biocraft Laboratories is a fully reporting biotechnology
company that recently achieved a series of scientific
breakthroughs, with implications for the global textile industry.
For further information, please visit www.KraigLabs.com.
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "could" or other words or phrases of similar import.
Similarly, statements in this release that describe the Company's
business strategy, outlook, objectives, plans, intentions or goals
should all be considered forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Management cautions that
its ability to further its research, and create commercially-viable
products may be affected by the competitive environment, the
Company's financial condition and its ability to raise sufficient
capital to meet the financial obligations of its business plan and
to fund its continuing operations.
Contact: Ben Hansel (720) 288-8495
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024